原标题：青岛打造现代海洋经济发展高地（总书记的关切·落地的回响） 从工业级、食品级到医药级，市场价格从一吨5万元、10万元到百万元，青岛涉海企业让海藻价值实现 飞跃。 一个海湾，能释放多少生产力？ 黄海之滨，向海而兴。2018年6月，习近平总书记在山东青岛考察时强调："海洋经济发展前途无量。建 设海洋强国，必须进一步关心海洋、认识海洋、经略海洋，加快海洋科技创新步伐。" 深入贯彻落实习近平总书记重要指示精神，青岛充分发挥特色优势，持续推进引领型现代海洋城市建 设，加快打造现代海洋经济发展高地。 一条鱼，怎么养好？ 大黄鱼登上全球首艘10万吨级智慧渔业大型养殖工船"国信1号"，大西洋鲑在全球首座全潜式深海渔业 养殖装备"深蓝1号"中长势喜人。 一株海藻，如何攀升价值链？ "海洋经济发展前途无量。建设海洋强国，必须进一步关心海洋、认识海洋、经略海洋，加快海洋科技 创新步伐。" ——2018年6月12日，习近平总书记在山东青岛考察时强调 "推进中国式现代化必须推动海洋经济高质量发展，走出一条具有中国特色的向海图强之路。"党的十八 大以来，习近平总书记指引我国海洋强国建设不断取得新成就。 2024年我国海洋生产总值首 ...

Core Insights - The development of the marine economy in China is projected to achieve significant growth, with the marine production value expected to exceed 10 trillion yuan in 2024, more than doubling since 2012 [1] - China leads the world in new orders for 14 out of 18 major ship types, and has maintained the highest production of marine products globally for several consecutive years [1] Group 1: Marine Economy Development - The construction of a marine power must focus on marine awareness, management, and technological innovation [1] - Qingdao is actively promoting the development of a modern marine economy, leveraging its unique advantages [1] Group 2: Innovations in Marine Industry - The "Guoxin 1" smart fishery vessel and the "Deep Blue 1" deep-sea aquaculture equipment represent advancements in marine aquaculture technology [2] - Qingdao's marine enterprises are enhancing the value of seaweed through various market applications, with prices reaching up to one million yuan per ton [3] Group 3: Marine Equipment Manufacturing - The marine equipment manufacturing sector is experiencing rapid growth, with significant projects underway and orders extending to 2028 for shipbuilding [7] Group 4: Modern Marine Industry System - Qingdao is implementing a "4+4+2" modern marine industry system to enhance traditional industries and foster new sectors, including marine pharmaceuticals and desalination [9] - The focus is on integrating industries to extend the value chain and improve overall productivity [9] Group 5: Policy and Strategic Direction - The "14th Five-Year Plan" emphasizes enhancing marine strategic capabilities and promoting high-quality development of the marine economy [10] - Local government officials are committed to advancing marine economic development in alignment with national directives [10]

Core Viewpoint - The article highlights the advancements in marine biomedicine in Qingdao, particularly focusing on the clinical trials of the marine polysaccharide drug BG136, which is the first of its kind in the world to enter clinical trials for cancer treatment [5][15]. Marine Biomedical Research - The Qingdao Marine Biomedical Research Institute aims to bridge the gap between scientific research and industrial application in marine biomedicine, promoting the transformation of research outcomes into marketable products [5][6]. - BG136, derived from Antarctic seaweed, activates the innate immune system to exert anti-tumor effects [6][15]. - The institute is also advancing other projects under the "Blue Pharmacy" initiative, including new drugs for chronic obstructive pulmonary disease (COPD) and hepatitis B, as well as an HPV treatment that has already been launched [6][15]. Industry Development - The Qingdao Marine Biomedical Research Institute is part of a broader strategy to create an integrated ecosystem for marine biomedical innovation, combining government, industry, academia, and finance [7]. - The marine biomedical industry in Qingdao is expected to exceed 38 billion yuan in output by 2024, with projections to reach a scale of 100 billion yuan by 2026 [15]. - The city has established a "4+2+4" marine industry system to foster emerging sectors, including marine pharmaceuticals and bio-products, while enhancing traditional industries [13][15]. Competitive Advantage - China's marine drug research capabilities rank among the top globally, with domestically developed marine drugs accounting for 28% of the global market [15]. - Qingdao has nurtured leading companies in the marine pharmaceutical sector, contributing to the formation of significant industry clusters in marine drugs, medical dressings, and health products [15].

Group 1 - The 2025 East Asia Marine Expo Marine Biomedicine Exhibition will be held in Qingdao, covering an exhibition area of 10,000 square meters with 85 participating enterprises and institutions [3][4] - The exhibition aims to build a full industry chain cooperation platform, showcasing the complete ecosystem and innovative achievements from marine biological resources to terminal biomedicine products [3][4] - Key technologies such as algal extraction are highlighted, showcasing the medicinal potential of algae, which is rich in polysaccharides, polyphenols, and other active substances [4][5] Group 2 - Leading companies in the industry, such as Qingdao Mingyue Algae Group, will present various algal functional materials and marine functional materials at the exhibition [4][5] - The exhibition will feature midstream enterprises with strong industrialization capabilities, focusing on new drug research and biopharmaceutical production [4][6] - Companies like Qingdao Guoxin Pharmaceutical, the first marine drug production enterprise in China, will showcase their innovative products, including BG136, which targets tumor immunotherapy [6][7] Group 3 - The exhibition will also gather downstream enterprises focusing on clinical application transformation and health product industrialization, including medical institutions and third-party testing organizations [6][7] - Notable products include health supplements developed by companies like Langyatai Dijia Pharmaceutical, which utilize unique marine biological components to regulate blood lipids and blood sugar [6][7] - The event aims to stimulate collaboration and innovation within the marine biomedicine sector, promoting a blue economy and a healthier future [7][8]